Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions
- PMID: 34692992
- PMCID: PMC8532210
- DOI: 10.1177/23743735211049655
Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions
Abstract
Uterine fibroids are noncancerous tumors associated with significant morbidity among symptomatic patients. While medical and surgical treatments have expanded, hysterectomy remains common. We interviewed women diagnosed with uterine fibroids (n = 47) to explore their experiences and recommendations for shared decision-making. A majority were non-Hispanic Black, highly educated (51.1%), and had graduate degrees (40.4%). Participants with both positive and negative provider experiences expressed a desire for a more proactive therapeutic approach, including a presentation by their provider of the spectrum of medical and surgical treatment options, and greater provider recognition of the impact of symptoms on quality of life. Women advocated for expanded shared decision-making that acknowledged their contribution to their own treatment plan and felt early screening and improved patient/provider education of uterine fibroid symptoms would facilitate greater congruence between treatment approaches and patient goals. Perceptions of insufficient input into their treatment plans frequently served as a barrier to care-seeking and treatment acceptance among women with uterine fibroid symptoms. Improved discussion of treatment options in the context of the unique symptom burden and values of the patient may facilitate greater provider trust and acceptance of uterine fibroid treatment.
Keywords: diagnosis; patient dismissal; quality of life; shared decision-making; uterine fibroids; uterine leiomyoma.
© The Author(s) 2021.
Conflict of interest statement
Declaration of Conflicting Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: KR, JBB, and MA report no conflicts of interest. EAS reports consulting for AbbVie, Bayer and ObsEva, and Myovant related to uterine fibroids and payment for development of educational content from UpToDate, Med Learning Group, PER, and PeerView. SV reports consulting for AbbVie, Myovant, and Bayer.
Similar articles
-
The management of uterine leiomyomas.J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
-
The management of uterine leiomyomas.J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22. J Obstet Gynaecol Can. 2003. PMID: 12738981
-
Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.J Racial Ethn Health Disparities. 2022 Aug;9(4):1184-1191. doi: 10.1007/s40615-021-01059-8. Epub 2021 May 19. J Racial Ethn Health Disparities. 2022. PMID: 34013445 Free PMC article.
-
The role of socioeconomic status in uterine fibroid awareness and treatment: a narrative review.Ther Adv Reprod Health. 2024 Nov 9;18:26334941241297634. doi: 10.1177/26334941241297634. eCollection 2024 Jan-Dec. Ther Adv Reprod Health. 2024. PMID: 39525322 Free PMC article. Review.
-
Uterine artery embolization as a treatment option for uterine myomas.Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. Obstet Gynecol Clin North Am. 2006. PMID: 16504811 Review.
Cited by
-
Uterine Weight as a Modifier of Black/White Racial Disparities in Minimally Invasive Hysterectomy Among Veterans with Fibroids in the Veterans Health Administration.Health Equity. 2022 Dec 16;6(1):909-916. doi: 10.1089/heq.2022.0130. eCollection 2022. Health Equity. 2022. PMID: 36636115 Free PMC article.
-
"In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.BMC Womens Health. 2024 Apr 12;24(1):233. doi: 10.1186/s12905-024-03008-z. BMC Womens Health. 2024. PMID: 38610011 Free PMC article.
-
Laparoscopic myomectomy without uterine manipulator for maintaining endometrial cavity integrity.Heliyon. 2024 Oct 18;10(20):e39550. doi: 10.1016/j.heliyon.2024.e39550. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39497957 Free PMC article.
-
Racial Disparities in Medical Management of Uterine Fibroids Prior to Myomectomy or Hysterectomy.J Racial Ethn Health Disparities. 2025 Aug;12(4):2279-2285. doi: 10.1007/s40615-024-02048-3. Epub 2024 Jun 17. J Racial Ethn Health Disparities. 2025. PMID: 38886279
-
Enhancing Uterine Fibroid Care: Clinician Perspectives on Diagnosis, Disparities, and Strategies for Improving Health Care.Womens Health Rep (New Rochelle). 2024 Mar 27;5(1):293-304. doi: 10.1089/whr.2023.0113. eCollection 2024. Womens Health Rep (New Rochelle). 2024. PMID: 38558944 Free PMC article.
References
-
- Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100‐7. - PubMed
-
- Bartels CB, Cayton KC, Chuong FS, Holthouser K, Arian SE, Abraham T, et al. An evidence-based approach to the medical management of fibroids: a systematic review. Clin Obstet Gynecol. 2016;59(1):30‐52. - PubMed
-
- Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043. - PubMed
-
- Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198(4):357‐66. - PubMed
LinkOut - more resources
Full Text Sources